In Vivo Measurement of GABA Transmission in Healthy Subjects and Schizophrenia Patients

Abstract

This study demonstrates, for the first time, an in vivo impairment in GABA transmission in schizophrenia, most prominent in antipsychotic-naive individuals. The impairment in GABA transmission appears to be linked to clinical symptoms, disturbances in cortical oscillations, and cognition.